From: A pilot open-label trial of minocycline in patients with autism and regressive features
Analyte | Cerebrospinal fluid (CSF) | Serum | Plasma | |||
---|---|---|---|---|---|---|
Z | P | Z | P | Z | P | |
TNFα | −0.45 | 0.66 | −1.78 | 0.074 |  | |
IL-6 | −0.36 | 0.72 | −1.75 | 0.08 | ||
CCL2 (MCP-1) | −1.78 | 0.075 | −1.27 | 0.24 | ||
CCL3 (MIP-1α) | −0.18 | 0.86 | −0.76 | 0.45 | ||
CCL5 (RANTES) | −0.73 | 0.47 | 0.66 | 0.61 | ||
CXCL8 (IL-8) | −0.45 | 0.66 | −1.99 | 0.047 | ||
BDNFb | −2.03 | 0.042 |  | −0.76 | 0.45 | |
Truncated-BDNF/α-2 Mc |  | −2.19 | 0.028 |  | ||
Mature-BDNF/α-2 M c | −0.87 | 0.386 | ||||
CD40L | −0.89 | 0.37 |  | −1.33 | 0.18 | |
GDNF | −0.37 | 0.71 | −1.83 | 0.07 | ||
HGF | −2.19 | 0.028 | −1.25 | 0.21 | ||
Leptin | −1.48 | 0.14 | −0.27 | 0.79 | ||
MMP-1 |  | −1.07 | 0.29 | |||
MMP-3 | −0.15 | 0.88 | ||||
MMP-7 | −1.89 | 0.059 | ||||
MMP-8 | −0.05 | 0.96 | ||||
MMP-9 | −1.38 | 0.17 |